EMBJ arrives at its May 5 Q1 2026 earnings call having shed nearly half its short interest in the past month — a striking capitulation by the bears just before the print.
The short-side retreat is the dominant story in the data. Estimated short interest has fallen roughly 50% over the past month, dropping to around 1.15 million shares by April 30. Days to cover clocks in at just 1.07 on the official FINRA reading. The ORTEX short score has eased from above 33 in mid-April to 29.4 — near the bottom of the scale — while borrow costs have stayed flat near 0.49% and the lending market remains wide open. This is not a stock with positioning pressure. The shorts have largely left the building ahead of the announcement.
Options reinforce the constructive tone. The put/call ratio has drifted down to 0.63, now running below its 20-day average of 0.73. Protective demand has eased sharply — back in late March and early April the PCR was running above 0.96, near its 52-week high of 0.99. That hedging wave has unwound. The stock itself is up 5.5% on the month to $62.61, trimming a modest -2.6% YTD loss, and momentum has been broadly positive even as the RSI sits at a neutral 46.
The analyst community is firmly in the bull camp. Nine buy ratings face no sell recommendations, and the consensus mean price target of $81.93 implies roughly 31% upside from current levels. JP Morgan raised its target to $84 from $80 in mid-March, reaffirming its Overweight rating — a directional signal the Street was unwilling to fade the rally. The EV/EBITDA multiple has expanded modestly over the past 30 days to 41.3x, but the PE ratio has pulled back by about 1.2 turns on the same timeframe, suggesting some rotation in how investors are framing value. BlackRock and Vanguard are the two largest holders, with BlackRock adding 630,000 shares as recently as April 23 — that is an active, post-tariff accumulation in the weeks just before the print.
The one note of caution in the data is the historical reaction pattern. The last two confirmed earnings events — March 2026 and March 11, 2026 — both produced sharp declines: the March 11 print saw the stock fall nearly 14% on the day and around 10% over the following week. The May 5 report will test whether the improved positioning and fading short interest reflect genuine fundamental confidence in Q1 delivery cadence and margin progress, or simply a relief rally in advance of results that the stock has historically struggled to sustain.
See the live data behind this article on ORTEX.
Open EMBJ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
